26605-36-7 Usage
General Description
N-Succinyl-L-diaminopimelic acid is a naturally occurring compound that is a derivative of the amino acid L-lysine. It is an important component of bacterial cell walls, where it functions as a crosslinking agent to provide structural support and rigidity. N-Succinyl-L-diaminopimelic acid is also a key precursor in the biosynthesis of peptidoglycan, a major component of bacterial cell walls. N-Succinyl-L-diaminopimelic acid has been studied for its potential as a target for the development of antibacterial agents, as it plays a critical role in maintaining the integrity of bacterial cell walls. Additionally, it has been used as a biomarker for detecting bacterial infections in clinical samples. Overall, N-Succinyl-L-diaminopimelic acid has important implications for understanding bacterial physiology and for the development of new antibacterial therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 26605-36-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,6,0 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 26605-36:
(7*2)+(6*6)+(5*6)+(4*0)+(3*5)+(2*3)+(1*6)=107
107 % 10 = 7
So 26605-36-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H18N2O7/c12-6(10(17)18)2-1-3-7(11(19)20)13-8(14)4-5-9(15)16/h6-7H,1-5,12H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)/t6-,7-/m0/s1
26605-36-7Relevant articles and documents
Synthesis and in vitro enzyme activity of peptide derivatives of bacterial cell wall biosynthesis inhibitors
Cox, Russell J.,Jenkins, Helen,Schouten, James A.,Stentiford, Rosie A.,Wareing, Katrina J.
, p. 2023 - 2036 (2007/10/03)
The enzyme diaminopimelate aminotransferase (DAP-AT) is a good potential target for the design of novel antibacterial agents. We have synthesised a series of peptide hydrazines based on the structure of the natural substrate of DAP-AT. These compounds show varied inhibition properties in vitro vs. DAP-AT from E. coli as well as moderate antimicrobial activity vs. E. coli. Examination of the kinetics of inhibition reveals that hydrazine, as well as the substituted hydrazino-peptides, shows two-phase slow-binding inhibition. Possible mechanisms for inhibition are discussed. The Royal Society of Chemistry 2000.